---
title: "Aura Biosciences announces special shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290102126.md"
description: "Aura Biosciences announced a virtual special shareholder meeting scheduled for August 5, 2026. Key agenda items include voting on a charter amendment to increase authorized common shares from 150 million to 500 million, and voting on Amendment No. 1 to the 2021 Stock Option and Incentive Plan to adjust the evergreen share increase formula to include pre-funded warrants."
datetime: "2026-06-17T20:31:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290102126.md)
  - [en](https://longbridge.com/en/news/290102126.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290102126.md)
generator: "portal-rs"
---

# Aura Biosciences announces special shareholder meeting

-   Aura Biosciences will hold a virtual special stockholder meeting on Aug. 5, 2026. \* Vote on a charter amendment to raise authorized common shares to 500,000,000 from 150,000,000. \* Vote on Amendment No. 1 to the 2021 Stock Option and Incentive Plan, adjusting the evergreen share increase formula to include pre-funded warrants. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-274232), on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [AURA.US](https://longbridge.com/en/quote/AURA.US.md)

## Related News & Research

- [MinRex calls shareholder vote on major incentive plan and prior securities issues](https://longbridge.com/en/news/297006491.md)
- [Egide proposes canceling up to 10% of shares via capital reduction vote at Sept. 10 meeting](https://longbridge.com/en/news/296915761.md)
- [Aptevo Therapeutics announces special shareholder meeting](https://longbridge.com/en/news/296649507.md)
- [Spruce Power reconvened annual shareholder meeting for vote on director slate, other proposals](https://longbridge.com/en/news/297053597.md)
- [Moleculin Biotech announces annual shareholder meeting](https://longbridge.com/en/news/296828733.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**